# A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects

> **NCT06387966** · PHASE1 · COMPLETED · sponsor: **Chengdu Zenitar Biomedical Technology Co., Ltd** · enrollment: 40 (actual)

## Conditions studied

- Heathly Subjects

## Interventions

- **DRUG:** Flonoltinib Maleate Tablets
- **DRUG:** Flonoltinib Maleate Tablets placebo

## Key facts

- **NCT ID:** NCT06387966
- **Lead sponsor:** Chengdu Zenitar Biomedical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-18
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387966, "A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06387966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*